Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 23

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 4
Chunk 23
---
 consideration of $15.0 million paid in the form of 8,571,428 shares (“ Consideration
Shares”) based on the $1.75 per share price pursuant to the CK Health Share Purchase Agreement.
An additional one million ordinary shares will be issued to the persons named in the Share Purchase Agreement if certain financial performance
milestones based on CK Health’s net income for the fiscal years 2024 and 2025 are met. The acquisition closed on
May 8, 2024. Meng Dong (James) Tan, a significant shareholder of EUDA is also a 40% shareholder of Fortress Cove Limited. For
the fiscal year ended December 31, 2024, revenue generated from CK Health accounted for approximately 2.1% of our total revenue.

Collaboration Agreement with Key Lock - April
2025

On April 22, 2025, CK Health
entered into a collaboration agreement with Key Lock Health Management Co., Ltd. (“ Key Lock”), an authorized distributor
of Guangdong Cell Biotech Co. Ltd. (“ Guangdong Cell Biotech”), a prominent player in stem cell therapies and regenerative
medicine, that develops autologous cell treatments and tailored medicines for various disorders. It currently has 37 established stem
cell and DNA medical treatment facilities in China and presence in Indonesia and Cambodia. Pursuant to the terms of a distribution agreement
between Guangdong Cell Biotech and Key Lock dated April 21, 2025, Key Lock is responsible for promoting and selling Guangdong Cell Biotech’s
stem cell therapy packages, managing sales, market development and customer support. Pursuant to the collaboration agreement between
CK Health and Key Lock, CK Health will purchase from Key Lock certain stem cell therapy services offered by Guangdong Cell Biotech at
certain pre-determined prices and market and sell these services in Singapore and Malaysia; and Key Lock will use its commercial endeavours
to ensure proper stem cell therapy services received by EUDA customers at one of Guangdong Cell Biotech’s treatment centers in
China. This collaboration agreement is terminable by either party with one month’s notice of termination.

Property
Management Services

EUDA’s
sales and marketing department is primarily responsible for planning and developing its overall marketing strategy, conducting market
research, coordinating the sales and marketing activities to attract new customers and maintain and strengthen relationships with existing
customers, managing the efforts in relation to tender bids and negotiating the terms of EUDA’s property management service and security service contracts.